Ads
related to: alzheimer's treatment- About Treatment
Learn more about the Alzheimer's
treatment option & how it works.
- Alzheimer's Disease Info
Learn about the stages of AD and
diagnostic tests for patients.
- Support & Resources
Patient and care partner support
available on the treatment website.
- For Care Partners
Help support your loved one. View
tips and infusion companion info.
- Sign Up For More Info
Get access to information all about
treatment & useful tips.
- Getting Started
Find infusion FAQs & tips for
getting started with treatment.
- About Treatment
Search results
Biogen shares maintain overweight rating By Investing.com
Investing.com· 6 days agoThe firm reiterated an Overweight rating on the stock, alongside a price target of $331.00. This...
Biogen is buying up an immune drug developer for $1.8 billion
Quartz· 6 days agoBiogen has agreed to a $1.15 billion upfront payment and up to $650 million in additional payments...
Swedish Growth Stocks With High Insider Ownership In May 2024
Simply Wall St. via Yahoo Finance· 2 days agoAs of May 2024, the Swedish market, like many global counterparts, exhibits a mix of challenges and...
Startup Plans To Perform Head Transplants Within 10 Years | 98ROCK | Crash & AJ
iHeartRadio· 6 days agoIn a mind-bending medical feat, neuroscience startup BrainBridge claims to have developed an...
Celebrities stand up for brain health at the Power of Love gala in Las Vegas
Out Traveler via Yahoo News· 6 days agoIt's hard, so I want to show support to other people and places like the Cleveland Clinic. What...
Letters: DeSantis bill signing at charter school not really about education but politics
The Florida Times-Union via Yahoo News· 2 days agoIt tears families apart and impacts quality of life for all Jacksonville residents. For the first...
Health Care: Republicans scrutinize FDA
Axios· 6 days agoPast Biden administration restrictions on Medicare coverage for a class of Alzheimer's drugs have angered some Republicans and renewed a debate over...
Acumen Pharmaceuticals (NASDAQ:ABOS) Issues Earnings Results
ETF DAILY NEWS· 7 days agoAcumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) issued its earnings results on Monday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus ...
Marama Launches New Website to Revolutionize Memory Care
Digital Journal· 2 days agoAbout Marama Marama provides exceptional memory care services in San Diego, with a focus on holistic...
Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential...
Fortune via Yahoo Finance· 3 days agoSome researchers are also testing whether these drugs can prevent Alzheimer’s disease. Even more,...
